Key result
Fibrinolysis for acute pulmonary embolism is considered life-saving in massive cases but remains controversial for submassive cases due to the risk of major bleeding.
Why the study?
Does fibrinolysis improve outcomes in patients with acute pulmonary embolism?
Population
Patients with acute pulmonary embolism, including massive and submassive presentations
Design
Review
Authors
Loading...
Supports selective fibrinolysis in massive PE; leaves open its net benefit in submassive cases pending randomized trials.
Does fibrinolysis improve outcomes in patients with acute pulmonary embolism?
Fibrinolysis is considered life-saving for massive PE but remains controversial for submassive PE due to the risk of major bleeding, particularly intracranial hemorrhage.
Piazza et al. (2010) conducted a review in Acute pulmonary embolism. Fibrinolysis was evaluated. Fibrinolysis for acute pulmonary embolism is considered life-saving in massive cases but remains controversial for submassive cases due to the risk of major bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: